ALB and infection: Perhaps the most robust evidence regarding human albumin use in cirrhosis comes from a recent overview of 300 papers, including 18 meta-analyses performed by Qi et al. The group concluded that albumin reduced mortality and renal impairment exclusively in those with SBP but not in those with non-SBP infections [68].